Evidence mounts for need to study Pfizer's Paxlovid for long COVID - Researchers say - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test the medicine for the debilitating condition, US researchers said on Thursday.

Pfizer's coronavirus disease pill Paxlovid is packaged in Ascoli, Italy.

It affects people who have had both mild and severe COVID-19, including children, and can be severe enough to keep people out of work. “There’s been a lot of hope that early antiviral therapy, in addition to preventing severe COVID, will prevent long COVID. And that might be true, but this case suggests that it won’t be true 100% of the time,” Peluso said.

“It provides evidence that we really need to study this soon, and … systematically, which means randomized trials,” said Peluso.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I'm waiting for the pill & pls help us before is too late. I think it must be our medicine forever in our medical records untill we or i die.

USA is monopolising health medicine

I hope ramaphosa is watching

Here is something that is newsworthy.

😂😂😂😂🚮🚮🚮🚮🚮🚮

We have been saying your vaccines are causing heart attacks and killing people.. 👺 Even your american masters are telling their people the truth now. This is proof SA govt & media are under full control of pharma giants.

Human test labs

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines